GRO-HD

  • Research type

    Research Study

  • Full title

    Glycaemic response to oral nutrition support during haemodialysis

  • IRAS ID

    161351

  • Contact name

    Helen MacLaughlin

  • Contact email

    helen.maclaughlin@nhs.net

  • Sponsor organisation

    King’s College Hospital NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 7 months, 28 days

  • Research summary

    Patients with kidney, or renal, failure require life-saving treatment with regular dialysis. Dialysis is a form of treatment that simulates some kidney functions; to remove harmful waste products and extra water from the blood. Almost one-third of people with kidney failure also have diabetes, as diabetes is one of the leading causes of kidney disease in the United Kingdom, usually due to poor blood sugar control over a long period of time. Malnutrition is common in patients needing dialysis, due to kidney failure causing fatigue, taste changes and a build up of waste products, which can reduce appetite. Treatment of malnutrition involves increasing both the energy and protein intake from food and drinks, and milk-drink style specialist nutrition drinks are often given to dialysis patients due to their specific dietary needs. These nutrition drinks can increase blood sugar levels and optimal control for diabetes may be difficult. This research study aims to measure the blood sugar response to a “slow-release sugar” nutrition drink specifically designed for dialysis patients, which may result in a lower blood sugar level, compared to standard nutrition drinks, consumed during a dialysis session. 20 patients with diabetes and having regular dialysis treatment will enrol in the study. Patients will be asked to drink 1 of 4 different nutrition drinks, once a week for 4 weeks during their regular dialysis treatment. Blood sugar levels will be measured from the blood samples taken from the dialysis machine over 2 hours and the maximum blood sugar reading and total blood sugar response will be measured. Differences between the 4 products will be measured with statistical analyses. The results will help to advise patients with diabetes and kidney failure on the most suitable type of nutrition drink to consume during dialysis.

  • REC name

    London - Camberwell St Giles Research Ethics Committee

  • REC reference

    14/LO/2193

  • Date of REC Opinion

    19 Dec 2014

  • REC opinion

    Favourable Opinion